A. Pascot

发表

C. Bouchard, J. Després, A. Tremblay, 1999, Diabetes care.

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

D. Gaudet, D. Prud'homme, J. Després, 2000, Circulation.

Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study.

J. Després, D. Gaudet, P. Julien, 2002, Atherosclerosis.

Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.

G. Dagenais, J. Després, I. Lemieux, 2001, Archives of internal medicine.

Impaired fasting glucose vs. glucose intolerance in pre‐menopausal women: distinct metabolic entities and cardiovascular disease risk?

J. Després, S. Weisnagel, A. Tremblay, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.

J. Després, A. Tremblay, D. Prud'homme, 2001, Journal of lipid research.

Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?

J. Després, D. Prud'homme, I. Lemieux, 2002, European journal of clinical investigation.

Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men.

C. Bouchard, J. Després, D. Prud'homme, 1999, Metabolism: clinical and experimental.

Influences of the PPARα-L162V polymorphism on plasma HDL2-cholesterol response of abdominally obese men treated with gemfibrozil

Y. Bossé, J. Després, M. Dumont, 2002, Genetics in Medicine.

A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma.

C. Couillard, B. Lamarche, A. Pascot, 2001, Journal of lipid research.

The small, dense LDL phenotype as a correlate of postprandial lipemia in men.

C. Bouchard, A. Tremblay, N. Bergeron, 2000, Atherosclerosis.

Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.

J. Després, A. Tremblay, I. Lemieux, 2003, Diabetes care.

Predictors of the development of impaired fasting glucose versus impaired glucose tolerance are partly different in men: a 6-year follow-up study

J. Després, S. Weisnagel, A. Tremblay, 2004, Diabetologia.

[Fat distribution and metabolism].

J. Després, S. Lemieux, A. Tchernof, 2001, Diabetes & metabolism.

Reduction of visceral adipose tissue during weight loss

A. Tremblay, É. Doucet, N. Alméras, 2002, European Journal of Clinical Nutrition.

Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome

C. Bouchard, J. Després, M. Vohl, 1999, International Journal of Obesity.

Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance

J. Després, A. Tremblay, D. Prud'homme, 2000, Diabetologia.

Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins.

J. Després, A. Tremblay, N. Bergeron, 2002, The American journal of clinical nutrition.

HDL particle size: a marker of the gender difference in the metabolic risk profile.

J. Després, A. Tremblay, D. Prud'homme, 2002, Atherosclerosis.

Effect of a low-glycaemic index–low-fat–high protein diet on the atherogenic metabolic risk profile of abdominally obese men

J. Turgeon, A. Tremblay, P. Poirier, 2001, British Journal of Nutrition.

Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.

J. Després, A. Tremblay, I. Lemieux, 2003, Metabolism: clinical and experimental.

Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.

J. Després, A. Tremblay, D. Prud'homme, 2001, Diabetes care.

Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity

J. Després, D. Prud'homme, N. Alméras, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.

J. Després, I. Lemieux, J. Bergeron, 2002, Kidney international.

Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.

J. Després, M. Dumont, D. Prud'homme, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Men With the Atherogenic Dyslipidemia of the Metabolic Syndrome Gemfibrozil Reduces Plasma C-Reactive Protein Levels in Abdominally Obese

J. Després, D. Prud'homme, I. Lemieux, 2003 .

Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.

C. Bouchard, J. Després, A. Tremblay, 2000, The Journal of clinical endocrinology and metabolism.

Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men.

Denis Prud'homme, J. Després, A. Tremblay, 2003, Atherosclerosis.

[Risk factors associated with obesity: a metabolic perspective].

I. Lemieux, A. Pascot, J. Després, 2000, Annales d'endocrinologie.